Cardiometabolic health in premature ovarian insufficiency

References

• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446.
   PubMed Web of Science ®Google Scholar
• Golezar S, Ramezani Tehrani F, Khazaei S, et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–411.
   PubMed Web of Science ®Google Scholar
• Xu X, Jones M, Mishra GD. Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort. Hum Reprod. 2020;35(1):203–211.
   PubMed Web of Science ®Google Scholar
• Roeters van Lennep JE, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiolog. 2016;23(2):178–186.
   PubMed Web of Science ®Google Scholar
• Wu X, Cai H, Kallianpur A, et al. Impact of premature ovarian failure on mortality and morbidity among Chinese women. PLoS One. 2014;9:e89597.
   PubMed Web of Science ®Google Scholar
• Panay N, Fenton A. Iatrogenic menopause following gynecological malignancy: time for action! Climacteric. 2016;19(1):1–2.
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Zekavat SM, Aragam K, et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA. 2019;322(24):2411–2421.
   PubMed Web of Science ®Google Scholar
• Upton CE, Daniels JP, Davies MC. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy. Climacteric. 2021;1–6. DOI:https://doi.org/10.1080/13697137.2021.1902496.
   Google Scholar
• Tsiligiannis S, Panay N, Stevenson JC. Premature ovarian insufficiency and long-term health consequences. Curr Vasc Pharmacol. 2019;17(6):604–609.
   PubMed Web of Science ®Google Scholar
• Choi Y, Chang Y, Kim BK, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015;80(4):399–405.
   PubMed Web of Science ®Google Scholar
• Gunning MN, Meun C, van Rijn BB, et al. Coronary artery calcification in middle-aged women with premature ovarian insufficiency. Clin Endocrinol (Oxf). 2019;91(2):314–322.
   PubMed Web of Science ®Google Scholar
• Knauff EA, Westerveld HE, Goverde AJ, et al. Lipid profile of women with premature ovarian failure. Menopause. 2008;15(5):919–923.
   PubMed Web of Science ®Google Scholar
• Gulhan I, Bozkaya G, Uyar I, et al. Serum lipid levels in women with premature ovarian failure. Menopause. 2012;19(11):1231–1234.
   PubMed Web of Science ®Google Scholar
• Podfigurna A, Męczekalski B. Cardiovascular health in patients with premature ovarian insufficiency. Management of long-term consequences. Prz Menopauzalny. 2018;17(3):109–111.
   PubMedGoogle Scholar
• Gunning MN, Meun C, van Rijn BB, et al. The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. PLoS One. 2020;15(3):e0229576.
   PubMed Web of Science ®Google Scholar
• Luo X, Cheng R, Zhang J, et al. Evaluation of body composition in POF and its association with bone mineral density and sex steroid levels. Gynecol Endocrinol. 2018;34(12):1027–1030.
   PubMed Web of Science ®Google Scholar
• Daan NM, Muka T, Koster MP, et al. Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age. J Clin Endocrinol Metab. 2016;101(9):3306–3315.
   PubMed Web of Science ®Google Scholar
• Freitas ATA, Donovan Giraldo AE, Rezende GP, et al. Body composition in women with premature ovarian insufficiency using hormone therapy and the relation to cardiovascular risk markers: a case-control study. Clin Endocrinol. 2021;94(1):111–118.
   PubMed Web of Science ®Google Scholar
• Corrigan EC, Nelson LM, Bakalov VK, et al. Effects of ovarian failure and X-chromosome deletion on body composition and insulin sensitivity in young women. Menopause. 2006;13(6):911–916.
   PubMed Web of Science ®Google Scholar
• Ates S, Yesil G, Sevket O, et al. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. Maturitas. 2014;79(3):306–310.
   PubMed Web of Science ®Google Scholar
• Canonico M, Plu-Bureau G, O’Sullivan MJ, et al. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative Hormone Therapy clinical trials. Menopause. 2014;21(3):214–220.
   PubMed Web of Science ®Google Scholar
• Lip GY, Blann AD, Jones AF, et al. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Am Heart J. 1997;134(4):764–771.
   PubMed Web of Science ®Google Scholar
• Kebapcilar AG, Kulaksizoglu M, Ipekci SH, et al. Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency. Arch Gynecol Obstet. 2013;288(1):207–212.
   PubMed Web of Science ®Google Scholar
• Ostberg JE, Storry C, Donald AE, et al. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf). 2007;66(4):557–564.
   PubMed Web of Science ®Google Scholar
• Guttmann H, Weiner Z, Nikolski E, et al. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf). 2001;54(2):159–164.
   PubMed Web of Science ®Google Scholar
• Cintron D, Rodriguez-Gutierrez R, Serrano V, et al. Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis. Endocrine. 2017;55(2):366–375.
   PubMed Web of Science ®Google Scholar
• Hallajzadeh J, Khoramdad M, Izadi N, et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018;25(10):1155–1164.
   PubMed Web of Science ®Google Scholar
• Brand JS, van der Schouw YT, Onland-Moret NC, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care. 2013;36(4):1012–1019.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Christou K, Artzouchaltzi AM, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(1):41–50.
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Kapphahn K, Hedlin H, et al. Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women’s Health Initiative. Menopause. 2017;24(1):64–72.
   PubMed Web of Science ®Google Scholar
• Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care. 2014;37(3):725–733.
   PubMed Web of Science ®Google Scholar
• Sharif K, Watad A, Bridgewood C, et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2019;33:1013–1023.
   Web of Science ®Google Scholar
• Jelenik T, Roden M. How estrogens prevent from lipid-induced insulin resistance. Endocrinology. 2013;154(3):989–992.
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis F, Manson JE, Stevenson JC, et al. Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocr Rev. 2017;38(3):173–188.
   PubMed Web of Science ®Google Scholar
• de Lauzon-Guillain B, Fournier A, Fabre A, et al. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort. Diabetologia. 2009;52(10):2092–2100.
   PubMed Web of Science ®Google Scholar
• Manson JE, Rimm EB, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of noninsulin-dependent diabetes mellitus. Ann Epidemiol. 1992;2(5):665–673.
   PubMedGoogle Scholar
• Slopien R, Wender-Ozegowska E, Rogowicz-Frontczak A, et al. Menopause and diabetes: EMAS clinical guide. Maturitas. 2018;117:6–10.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
   PubMed Web of Science ®Google Scholar
• Wenger NK. Coronary heart disease: an older woman’s major health risk. BMJ. 1997;315(7115):1085–1090.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Theocharis P, Lallas K, et al. Early menopause is associated with increased risk of arterial hypertension: a systematic review and meta-analysis. Maturitas. 2020;135:74–79.
   PubMed Web of Science ®Google Scholar
• Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997;126(10):761–767.
   PubMed Web of Science ®Google Scholar
• Turnbull F, Woodward M, Neal B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–2680.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138.
   PubMed Web of Science ®Google Scholar
• Libby P, Hansson GK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015;116(2):307–311.
   PubMed Web of Science ®Google Scholar
• Fairweather D. Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol. 2014;8(Suppl 3):49–59.
   PubMedGoogle Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–574.
   PubMed Web of Science ®Google Scholar
• Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol. 2018;315(6):H1569–H1588.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu C, Ye H, et al. Inflamm-aging: a new mechanism affecting premature ovarian insufficiency. J Immunol Res. 2019; 2019:8069898.
   PubMed Web of Science ®Google Scholar
• Agca R, Heslinga SC, van Halm VP, et al. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart. 2016;102(10):790–795.
   PubMed Web of Science ®Google Scholar
• Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol. 2006;47(10):1976–1983.
   PubMed Web of Science ®Google Scholar
• Laven JSE, Visser JA, Uitterlinden AG, et al. Menopause: genome stability as new paradigm. Maturitas. 2016;92:15–23.
   PubMed Web of Science ®Google Scholar
• Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907–3913.
   PubMed Web of Science ®Google Scholar
• Van Bommel MHD, de Jong MA, Steenbeek MP, et al. No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. J Cardiol. 2020;S0914-5087(20)30364–6.
   PubMed Web of Science ®Google Scholar
• Parashar S, Reid KJ, Spertus JA, et al. Early menopause predicts angina after myocardial infarction. Menopause. 2010;17(5):938–945.
   PubMed Web of Science ®Google Scholar
• Joshi PH, Blaha MJ, Budoff MJ, et al. The 10-year prognostic value of zero and minimal CAC. JACC Cardiovasc Imaging. 2017;10(8):957–958.
   PubMed Web of Science ®Google Scholar
• Johansson BW, Kaij L, Kullander S, et al. On some late effects of bilateral oophorectomy in the age range 15–30 years. Acta Obstet Gynecol Scand. 1975;54(5):449–461.
   PubMed Web of Science ®Google Scholar
• Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020;371:m3502.
   PubMed Web of Science ®Google Scholar
• Zhu D, Chung HF, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553–e564.
   PubMed Web of Science ®Google Scholar
• Atsma F, Bartelink ML, Grobbee DE, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13(2):265–279.
   PubMed Web of Science ®Google Scholar
• Muka T, Oliver-Williams C, Kunutsor S, et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016;1(7):767–776.
   PubMed Web of Science ®Google Scholar
• Tao XY, Zuo AZ, Wang JQ, et al. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2016;19(1):27–36.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69(11):1074–1083.
   PubMed Web of Science ®Google Scholar
• Ley SH, Li Y, Tobias DK, et al. Duration of reproductive life span, age at menarche, and age at menopause are associated with risk of cardiovascular disease in women. J Am Heart Assoc. 2017;6:e006713.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, de Andrade M, et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7(10):821–828.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16(1):15–23.
   PubMed Web of Science ®Google Scholar
• Løkkegaard E, Jovanovic Z, Heitmann BL, et al. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas. 2006;53(2):226–233.
   PubMed Web of Science ®Google Scholar
• Christ JP, Gunning MN, Palla G, et al. Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency. Fertil Steril. 2018;109(4):594–600.E1.
   PubMed Web of Science ®Google Scholar
• Langrish JP, Mills NL, Bath LE, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension. 2009;53(5):805–811.
   PubMed Web of Science ®Google Scholar
• Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937.
   PubMed Web of Science ®Google Scholar
• Hamoda H. The British Menopause Society and Women’s Health Concern recommendations on the management of women with premature ovarian insufficiency. Post Reprod Health. 2017;23(1):22–35.
   PubMedGoogle Scholar
• Cartwright B, Robinson J, Seed PT, et al. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab. 2016;101(9):3497–3505.
   PubMed Web of Science ®Google Scholar
• Panay N, Fenton A. Premature ovarian insufficiency: working towards an international database. Climacteric. 2012;15(4):295–296.
   PubMed Web of Science ®Google Scholar